LEXARIA BIOSCIENCE CORP. Related Party Transaction, Amounts of Transaction
LEXARIA BIOSCIENCE CORP. (LEXX) reported Related Party Transaction, Amounts of Transaction of $375.26 thousand for the 6-month period ending 2021-02-28, per its 10-Q filed 2021-04-14.
Discontinued › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2021-04-14
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for the quarter ending 2021-02-28 was $206.24K, a 42.33% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for the quarter ending 2020-11-30 was $169.01K, a 0.25% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for the quarter ending 2020-08-31 was $233.64K, a 4.24% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for the quarter ending 2020-05-31 was $633.40K, a 281.65% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for fiscal 2020 was $1.39M, a 64.39% increase from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for fiscal 2019 was $847.51K, a 75.38% decline from fiscal 2018.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for fiscal 2018 was $3.44M, a 521.58% increase from fiscal 2017.
- LEXARIA BIOSCIENCE CORP. related party transaction, amounts of transaction for fiscal 2017 was $553.86K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2021-02-28 | $206.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $375.26K 10-Q · filed 2021-04-14 | $608.90K derived: sum of 3 quarters · filed 2021-04-14 | $1.24M derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-11-30 | $169.01K 10-Q · filed 2021-01-14 | $402.66K derived: sum of 2 quarters · filed 2021-01-14 | $1.04M derived: sum of 3 quarters · filed 2021-01-14 | $1.39M derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-08-31 | $233.64K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $867.05K derived: sum of 2 quarters · filed 2020-10-15 | $1.22M derived: sum of 3 quarters · filed 2021-04-14 | $1.39M 10-K · filed 2020-10-15 |
| 2020-05-31 | $633.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | $991.01K derived: sum of 2 quarters · filed 2021-04-14 | $1.16M 10-Q · filed 2020-06-29 | $1.38M derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-02-29 | $357.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $526.19K 10-Q · filed 2021-04-14 | $750.33K derived: sum of 3 quarters · filed 2021-04-14 | $916.30K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $168.59K 10-Q · filed 2021-01-14 | $392.73K derived: sum of 2 quarters · filed 2021-01-14 | $558.69K derived: sum of 3 quarters · filed 2021-01-14 | $918.40K derived: sum of 4 quarters · filed 2021-01-14 |
| 2019-08-31 | $224.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $390.11K derived: sum of 2 quarters · filed 2020-10-15 | $749.82K derived: sum of 3 quarters · filed 2020-10-15 | $847.51K 10-K · filed 2020-10-15 |
| 2019-05-31 | $165.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | $525.67K derived: sum of 2 quarters · filed 2020-06-29 | $623.38K 10-Q · filed 2020-06-29 | $1.19M derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-02-28 | $359.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $457.41K 10-Q · filed 2020-04-03 | $1.03M derived: sum of 3 quarters · filed 2020-04-03 | $3.48M derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-11-30 | $97.70K 10-Q · filed 2020-01-09 | $669.23K derived: sum of 2 quarters · filed 2020-01-09 | $3.12M derived: sum of 3 quarters · filed 2020-01-09 | $3.44M derived: sum of 4 quarters · filed 2020-01-09 |
| 2018-08-31 | $571.53K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $3.02M derived: sum of 2 quarters · filed 2019-11-14 | $3.34M derived: sum of 3 quarters · filed 2019-11-14 | $3.44M 10-K · filed 2019-11-14 |
| 2018-05-31 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $2.77M derived: sum of 2 quarters · filed 2019-07-08 | $2.87M 10-Q · filed 2019-07-08 | $3.12M derived: sum of 4 quarters · filed 2019-07-08 |
| 2018-02-28 | $317.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $419.75K 10-Q · filed 2019-04-15 | $670.44K derived: sum of 3 quarters · filed 2019-04-15 | $762.41K derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-11-30 | $102.11K 10-Q · filed 2019-01-11 | $352.81K derived: sum of 2 quarters · filed 2019-01-11 | $444.77K derived: sum of 3 quarters · filed 2019-01-11 | $532.49K derived: sum of 4 quarters · filed 2019-01-11 |
| 2017-08-31 | $250.69K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $342.66K derived: sum of 2 quarters · filed 2018-11-14 | $430.37K derived: sum of 3 quarters · filed 2018-11-14 | $553.86K 10-K · filed 2018-11-14 |
| 2017-05-31 | $91.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $179.68K derived: sum of 2 quarters · filed 2018-07-13 | $303.17K 10-Q · filed 2018-07-13 | |
| 2017-02-28 | $87.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $211.20K 10-Q · filed 2018-04-12 | ||
| 2016-11-30 | $123.48K 10-Q · filed 2018-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |